Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent and now accounts for half of all heart failure cases. This rise is largely attributed to growing rates of obesity, hypertension, and diabetes. Despite its prevalence, the pathophysiological mechanisms of HFpEF are not f...
Príomhchruthaitheoirí: | Henry, JA, Couch, LS, Rider, OJ |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
MDPI
2024
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Intentional weight loss as a novel treatment for heart failure with preserved ejection fraction
de réir: Hundertmark, MJ, et al.
Foilsithe / Cruthaithe: (2021) -
Heart failure with preserved ejection fraction
de réir: Harper, A, et al.
Foilsithe / Cruthaithe: (2018) -
Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction
de réir: Burrage, MK, et al.
Foilsithe / Cruthaithe: (2021) -
Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction
de réir: Xiao Wang, et al.
Foilsithe / Cruthaithe: (2024-11-01) -
The Role of Myocardial Ischemia in the Course of Heart Failure with Preserved Ejection Fraction in Patients with Cardiorenal Metabolic Syndrome
de réir: Yevhen Yu. Marushko, et al.
Foilsithe / Cruthaithe: (2024-09-01)